Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Nyxoah SA (NYXH : NSDQ)

• Company Description    Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. Number of Employees: 154

• Price / Volume Information    Yesterday's Closing Price: $2.87 Daily Weekly Monthly 20 Day Moving Average: 35,931 shares Shares Outstanding: 38.76 (millions) Market Capitalization: $111.24 (millions) Beta: 1.56 52 Week High: $8.59 52 Week Low: $2.72 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -6.21% -10.79% 12 Week -38.94% -43.55% Year To Date -37.61% -42.64%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL RUE EDOUARD BELIN 12 - MONT-SAINT-GUIBERT,C9 1435 BEL ph: 321-022-2355 fax: 321-045-9075 ir@nyxoah.com http://www.nyxoah.com

• General Corporate Information    Officers Olivier Taelman - Chief Executive Officer and Director Robelga SRL - Chairman John Landry - Chief Financial Officer Kevin Rakin - Director Pierre Gianello - Director Peer Information Nyxoah SA (HLIS) Nyxoah SA (AZTA) Nyxoah SA (APYI) Nyxoah SA (RNVA) Nyxoah SA (HMSY) Nyxoah SA (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: B6S7WD106 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/17/26 Share - Related Items Shares Outstanding: 38.76 Most Recent Split Date: (:1) Beta: 1.56 Market Capitalization: $111.24 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.53 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.80 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/17/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.65 Price/Cash Flow: - Price / Sales: 6.23 EPS Growth vs. Year Ago Period: 31.75% vs. Previous Quarter: 36.76% Sales Growth vs. Year Ago Period: 566.40% vs. Previous Quarter: 13.50% ROE 03/31/26 - -163.73 12/31/25 - -139.18 09/30/25 - -101.99 ROA 03/31/26 - -80.24 12/31/25 - -79.53 09/30/25 - -66.74 Current Ratio 03/31/26 - 0.99 12/31/25 - 1.25 09/30/25 - 1.70 Quick Ratio 03/31/26 - 0.88 12/31/25 - 1.16 09/30/25 - 1.41 Operating Margin 03/31/26 - -543.21 12/31/25 - -884.69 09/30/25 - -1,457.97 Net Margin 03/31/26 - -543.21 12/31/25 - -884.69 09/30/25 - -1,457.97 Pre-Tax Margin 03/31/26 - -535.15 12/31/25 - -888.96 09/30/25 - -1,411.65 Book Value 03/31/26 - 1.08 12/31/25 - 1.43 09/30/25 - 1.64 Inventory Turnover 03/31/26 - 1.20 12/31/25 - 0.72 09/30/25 - 0.38 Debt-to-Equity 03/31/26 - 0.53 12/31/25 - 0.37 09/30/25 - 0.40 Debt-to-Capital 03/31/26 - 34.49 12/31/25 - 27.15 09/30/25 - 28.36

Powered by Zacks Investment Research ©